Lobbying client · LD-2 disclosures
Solvay Pharmaceuticals Inc
Georgia
12 filings from 2 registrants · 2008–2010 · latest filed Aug 4, 2010
Reported on its behalf
$230K
every LD-2 on file
Its own filed spend
$160K
lobbying for itself
Fees to outside firms
$70K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Pharmacy
PHA
7 filings
$210K on those filings
Taxation/Internal Revenue Code
TAX
6 filings
$200K on those filings
Medicare/Medicaid
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Patroski Lawson Solvay Pharmaceuticals, Inc.7 filingsthrough 2010
- Brett G Kappel Vorys, Sater, Seymour and Pease LLP5 filingsthrough 2009
- RANDAL C TEAGUE sr Vorys, Sater, Seymour and Pease LLP4 filingsthrough 2008
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: solvay-pharmaceuticals-inc.